PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression

Documenti analoghi

• Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC - a computational study
  di: Bates, Amber M., et al.
  Pubblicazione: (2017)
• Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
  di: Brogden, Kim A., et al.
  Pubblicazione: (2018)
• Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
  di: Brogden, Kim A., et al.
  Pubblicazione: (2018)
• Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis
  di: Mohammad Reza Javan, et al.
  Pubblicazione: (2016-08-01)
• Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
  di: Yunzhou Pu, et al.
  Pubblicazione: (2022-05-01)